Table 2.
Estimated prevalencea of STIs in populations surveyed, based on reference laboratory testing
| Country | Chlamydia | Gonorrhoea | Trichomoniasis |
|---|---|---|---|
| Morocco | 20.3% (81/399) | 2.8% (11/399) | 39.5% (158/400) |
| Guatemala (Site 1) | 19.8% (17/86) | 2.3% (2/86) | 15.1% (13/86) |
| South Africa | 38.2% (305/799) | 20.0% (159/794) | 15.6% (124/795) |
| Australia | Test not performed | Test not performed | 17.5% (14/80) |
| Pooled Prevalence | 31.1% (403/1284) | 13.4% (172/1279) | 22.7% (309/1361) |
STIs = Sexually transmitted infections, Chlamydia = Chlamydia trachomatis, Gonorrhoea = Neisseria gonorrhoeae, Trichomoniasis = Trichomonas vaginalis
aEstimate of prevalence based on positive results reported by the reference laboratory/total number of valid tests performed by the laboratory